| Cash Flow | 2025-09-30 | 2024-09-30 | 2023-09-30 | 2022-09-30 |
|---|---|---|---|---|
| Net income from continuing operations | 1,678 | 1,705 | 1,530 | 1,635 |
| Depreciation and amortization | 2,462 | 2,286 | 2,288 | 2,229 |
| Share-based compensation | 258 | 247 | 259 | 233 |
| Deferred income taxes | -474 | -211 | -622 | -120 |
| Trade receivables, net | -71 | 453 | 290 | -32 |
| Inventories | 410 | -98 | 15 | 631 |
| Prepaid expenses and other | 276 | -23 | -192 | 436 |
| Accounts payable, income taxes and other liabilities | -185 | 625 | -517 | -473 |
| Pension obligation | 23 | -70 | 112 | -55 |
| Excess tax benefits from payments under share-based compensation plans | - | - | -19 | -32 |
| Gain on sale of business | 0 | 0 | 268 | - |
| Product remediation-related charges | 98 | 38 | 653 | - |
| Product liability-related charges | - | - | 26 | 21 |
| Other, net | -186 | 445 | 377 | -4 |
| Net cash provided by continuing operating activities | 3,430 | 3,844 | 2,990 | 2,471 |
| Capital expenditures | 760 | 725 | 874 | 973 |
| Purchases of investments, net | - | 421 | - | - |
| Maturities and sales (purchases) of investments, net | -422 | - | - | - |
| Acquisitions, net of cash acquired | 0 | 3,924 | 0 | 2,070 |
| Proceeds from divestitures, net | 0 | 0 | 540 | - |
| Other, net | 480 | 444 | 382 | 178 |
| Net cash used for continuing investing activities | - | -5,514 | -716 | -3,220 |
| Net cash used for investing activities | -818 | - | - | - |
| Change in short-term debt | 455 | 400 | -230 | 230 |
| Change in credit facility borrowings | - | - | - | 0 |
| Proceeds from long-term debt | 0 | 4,517 | 1,662 | 497 |
| Distribution from embecta corp. (see note 2) | - | 0 | 0 | 1,266 |
| Net transfer of cash to embecta upon spin-off | - | 0 | 0 | 265 |
| Payments of debt | 1,789 | 1,142 | 2,155 | 805 |
| Proceeds from issuance of equity securities | - | - | - | 0 |
| Repurchase of common stock | 1,000 | 500 | 0 | 500 |
| Dividends paid | 1,196 | 1,100 | 1,114 | 1,082 |
| Other, net | -87 | -89 | -120 | -77 |
| Net cash provided by (used for) continuing financing activities | - | 2,087 | -1,956 | -736 |
| Net cash (used for) provided by financing activities | -3,617 | - | - | - |
| Net cash used for operating activities of discontinued operations | 0 | -46 | -1 | 163 |
| Net cash used for investing activities | - | 0 | 0 | -11 |
| Net cash provided by financing activities | - | 0 | 0 | 145 |
| Net cash (used for) provided by discontinued operations | - | -46 | -1 | 298 |
| Effect of exchange rate changes on cash and equivalents and restricted cash | 0 | 4 | 5 | -45 |
| Net (decrease) increase in cash and equivalents and restricted cash | -1,005 | 375 | 322 | -1,233 |
| Cash and cash equivalents at beginning of period | 1,856 | 1,481 | 1,159 | 2,392 |
| Cash and cash equivalents at end of period | 851 | 1,856 | 1,481 | 1,159 |
BECTON DICKINSON & CO (BDX)
BECTON DICKINSON & CO (BDX)